middle.news
Can Entropy’s TRP-8803 Transform Binge Eating Disorder Treatment?
8:42am on Thursday 22nd of January, 2026 AEDT
•
Healthcare
Read Story
Can Entropy’s TRP-8803 Transform Binge Eating Disorder Treatment?
8:42am on Thursday 22nd of January, 2026 AEDT
Key Points
First patient in TRP-8803 BED trial completes 4-week follow-up with positive outcomes
Clinically meaningful improvements in binge eating severity, mood, and emotional regulation
IV-infused psilocin offers precise control over psychedelic therapy delivery
Trial to continue with additional patients and dose escalation in 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Entropy Neurodynamics (ASX:ENP)
OPEN ARTICLE